XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Apr. 01, 2017
Cash Flows from Operating Activities:      
Net income (loss) $ 55,019 $ 45,572 $ (26,268)
Non-cash items:      
Depreciation and amortization 109,418 89,247 89,733
Impairment of assets 21,170 2,673 75,348
Share-based compensation expense 17,188 13,025 9,150
Gain on divestiture 0 (8,000) 0
Deferred tax provision (benefit) 13,351 (5,828) (6,800)
Unrealized (gain) loss from hedging activities (24) (649) 517
Provision for losses on accounts receivable and inventory 6,325 2,639 11,381
Other non-cash operating activities (416) 1,692 860
Change in operating assets and liabilities:      
Change in accounts receivable (38,064) 5,087 3,155
Change in inventories (39,322) 14,385 (1,552)
Change in prepaid income taxes (3,594) 1,436 1,395
Change in other assets and other liabilities 494 17,670 (18,253)
Change in accounts payable and accrued expenses 17,736 41,401 21,072
Net cash provided by operating activities 159,281 220,350 159,738
Cash Flows from Investing Activities:      
Capital expenditures (118,961) (74,799) (76,135)
Proceeds from divestiture 0 9,000 0
Proceeds from sale of property, plant and equipment 2,813 2,758 2,822
Net cash used in investing activities (116,148) (63,041) (73,313)
Cash Flows from Financing Activities:      
Term loan borrowings 347,780 0 0
Repayment of term loan borrowings (266,853) (61,654) (42,683)
Net increase (decrease) in short-term loans 15,000 671 (50,727)
Proceeds from employee stock purchase plan 3,254 3,246 3,560
Proceeds from exercise of stock options 10,191 37,094 29,437
Share repurchases (160,000) (100,000) 0
Net cash used in financing activities (50,628) (120,643) (60,413)
Effect of exchange rates on cash and cash equivalents (3,323) 3,939 (1,571)
Net Change in Cash and Cash Equivalents (10,818) 40,605 24,441
Cash and Cash Equivalents at Beginning of Year 180,169 139,564 115,123
Cash and Cash Equivalents at End of Year 169,351 180,169 139,564
Supplemental Disclosures of Cash Flow Information:      
Interest paid 13,116 7,663 7,850
Income taxes paid 8,205 9,083 6,957
Transfers from inventory to fixed assets for placement of Haemonetics equipment $ 16,345 $ 8,963 $ 6,255